Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy
- PMID: 18413205
- DOI: 10.1016/j.jdiacomp.2007.12.001
Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy
Abstract
CXC chemokines are particularly significant for leukocyte infiltration in inflammatory diseases. Recent reports have shown that inflammation is one of potential pathogenic mechanisms for diabetic nephropathy. However, information on inflammation related with CXC chemokines in human Type 2 diabetic nephropathy still remains scarce. We measured urinary and serum levels of three CXC chemokines, CXCL5, CXCL8 and CXCL9, in 45 Type 2 diabetic patients (DM), 42 primary renal disease (PRD) patients and 22 healthy controls by enzyme-linked immunosorbent assay. Urinary levels of CXCL5, CXCL8 and CXCL9 in DM were significantly elevated compared to those in controls (P<.0001, P<.01, P<.001; respectively). They increased consistent with urinary albumin excretion rate (UAER) and correlated with UAER in partial correlation analyses (r=0.41, P<.01; r=0.40, P<.01; r=0.45, P<.01; respectively). Urinary levels of CXCL5 in DM were significantly interrelated to HbA(1c) (r=0.42, P<.01). On the other hand, PRD showed significant increased levels of urinary CXCL8 and CXCL9 compared to controls (P<.001, P<.01; respectively), and so did PRD as UAER increased. However, there were no significant elevations of urinary levels of CXCL5 in PRD in spite of the increased UAER. We found significant associations of UAER in DM with diabetes duration, 1/serum creatinine, urinary CXCL5 (adjusted R(2)=0.67, P<.0001) or CXCL9 (adjusted R(2)=0.69, P<.0001) in a stepwise multiple regression analysis. These results suggest that these three CXC chemokines may be involved in the progression of human Type 2 diabetic nephropathy and that CXCL5 may be of use for telling diabetic nephropathy from primary renal diseases.
Similar articles
-
Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.Diabet Med. 2004 Jun;21(6):545-51. doi: 10.1111/j.1464-5491.2004.01200.x. Diabet Med. 2004. PMID: 15154937
-
Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.Nephrol Dial Transplant. 2006 Dec;21(12):3428-34. doi: 10.1093/ndt/gfl469. Epub 2006 Aug 25. Nephrol Dial Transplant. 2006. PMID: 16935891
-
Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.Diabet Med. 2005 Jan;22(1):14-20. doi: 10.1111/j.1464-5491.2004.01295.x. Diabet Med. 2005. PMID: 15606685
-
Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation.Nephrology (Carlton). 2005 Oct;10 Suppl:S32-6. doi: 10.1111/j.1440-1797.2005.00454.x. Nephrology (Carlton). 2005. PMID: 16174285 Review.
-
Diabetic nephropathy and cardiovascular diseases.Rocz Akad Med Bialymst. 2005;50:122-5. Rocz Akad Med Bialymst. 2005. PMID: 16358950 Review.
Cited by
-
Overexpression of acetyl-coenzyme A carboxylase beta increases proinflammatory cytokines in cultured human renal proximal tubular epithelial cells.Clin Exp Nephrol. 2010 Aug;14(4):315-24. doi: 10.1007/s10157-010-0296-x. Epub 2010 Jun 1. Clin Exp Nephrol. 2010. PMID: 20514549
-
CXCL5 secreted from macrophages during cold exposure mediates white adipose tissue browning.J Lipid Res. 2021;62:100117. doi: 10.1016/j.jlr.2021.100117. Epub 2021 Sep 16. J Lipid Res. 2021. PMID: 34537202 Free PMC article.
-
CXCL5 inhibits excessive oxidative stress by regulating white adipocyte differentiation.Redox Biol. 2022 Aug;54:102359. doi: 10.1016/j.redox.2022.102359. Epub 2022 Jun 3. Redox Biol. 2022. PMID: 35696764 Free PMC article.
-
T cells and their products in diabetic kidney disease.Front Immunol. 2023 Jan 26;14:1084448. doi: 10.3389/fimmu.2023.1084448. eCollection 2023. Front Immunol. 2023. PMID: 36776877 Free PMC article. Review.
-
Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry.Front Endocrinol (Lausanne). 2023 Jan 6;13:1018608. doi: 10.3389/fendo.2022.1018608. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686486 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous